Literature DB >> 28457702

Medical table: A major tool for antimicrobial stewardship policy.

P-M Roger1, E Demonchy2, K Risso2, J Courjon2, S Leroux2, E Leroux2, É Cua2.   

Abstract

Infectious diseases are unpredictable, with heterogeneous clinical presentations, diverse pathogens, and various susceptibility rates to anti-infective agents. These features lead to a wide variety of clinical practices, which in turn strongly limits their evaluation. We have been using a medical table since 2005 to monitor the medical activity in our department. The observation of heterogeneous therapeutic practices led to drafting up our own antibiotic guidelines and to implementing a continuous evaluation of their observance and impact on morbidity and mortality associated with infectious diseases, including adverse effects of antibiotics, duration of hospital stay, use of intensive care, and deaths. The 10-year analysis of medical practices using the medical table is based on more than 10,000 hospitalizations. It shows simplified antibiotic therapies and a reduction in infection-related morbidity and mortality. The medical table is a major tool for antimicrobial stewardship, leading to constant benefits for patients.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antibiothérapie; Antibiotic therapy; Antimicrobial stewardship; Bacterial resistance; Bon usage des antibiotiques; Medical table; Résistance bactérienne; Tableau de bord

Mesh:

Substances:

Year:  2017        PMID: 28457702     DOI: 10.1016/j.medmal.2017.03.005

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  3 in total

1.  Macrolides or fluoroquinolones as enteral antibiotic therapy for non-ICU legionellosis.

Authors:  Renaud Scussel; Karine Risso; Elisa Demonchy; Céline Michelangeli; Pierre-Marie Roger
Journal:  Infection       Date:  2019-07-10       Impact factor: 3.553

2.  Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome.

Authors:  Camille Klotz; Johan Courjon; Céline Michelangeli; Elisa Demonchy; Raymond Ruimy; Pierre-Marie Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

3.  Amoxicillin/clavulanic acid+aminoglycoside as empirical antibiotic treatment in severe community-acquired infections with diagnostic uncertainty.

Authors:  Johan Courjon; David Chirio; Elisa Demonchy; Céline Michelangeli; Nicolas Degand; Pierre-Marie Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-01       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.